Stocks and Investing Stocks and Investing
Mon, May 5, 2025
Sun, May 4, 2025

Merck to invest $1 billion in new Delaware plant to boost US manufacturing


Published on 2025-05-04 19:01:11 -
  Print publication without navigation

  • The new facility will produce biologic drugs and Keytruda, becoming Merck's first in-house U.S. site to make the blockbuster cancer treatment, the company said. Merck said last week its biggest tariff exposure is through Keytruda and it has enough U.S. inventory for this year. Merck opened a $1 billion facility at its North Carolina site last month to boost U.S. production.

Merck & Co. has announced a $1 billion investment to expand its manufacturing facility in Durham County, Delaware, aimed at increasing the production of pharmaceuticals, including vaccines and biologics. This expansion is expected to create 300 new jobs and enhance the company's capabilities in meeting global demand for its products. The project, which underscores Merck's commitment to innovation and growth in the life sciences sector, is set to be completed by 2027 and will significantly contribute to the local economy.

Read the Full Reuters Article at:
[ https://www.aol.com/news/merck-invest-1-billion-delaware-100045287.html ]